Replies to post #38903 on Humanigen Inc (fka HGENQ)

[cowtown jay]

I would like nothing more than to see us once again trading at a level that would entice management to sell shares.

I only hope that the share price can be run up on zero volume into the $20 range prior to whatever day follows our after-market-hours news. I don't want to begin selling too cheaply. And I mean what I said in my pinned post, that a Market Cap of $8.5B could be conservative. Pantginis' colleague at HC Wainwright had a target price of over $200 for the GSK/Vir sotrovimab mAb, until it was shelved due to lacking the ability to treat the new variants.

Due to the drain on our resources, we likely don't have the ability now to fully commercialize lenz for covid without a stock play, a stockpile order with a Defense Procurement Order, a partnership, or some combination of all of this.

And we may not have any of that, without an Authorization of Approval of lenz, to treat one of the indications in our pipeline.

So I hope for the best for management. They have the products, and they have done what it takes to be approved or authorized.